Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium

Medicine & Life Sciences

• Coronavirus 100%
• Transplant Recipients 73%
• Liver Transplantation 72%
• HIV 54%
• Kidney 42%
• Incidence 38%
• GS-5734 24%
• Tissue Donors 17%
• SARS Virus 16%
• tocilizumab 16%
• Transplants 14%
• Lymphocyte Count 12%
• Palliative Care 10%
• Hispanic Americans 10%
• Immunosuppression 10%
• Critical Care 9%
• Immunosuppressive Agents 9%
• Intensive Care Units 9%
• Steroids 8%
• Oxygen 8%
• RNA 7%
• T-Lymphocytes 7%
• Liver 5%
• Mortality 5%
• Infections 5%
• Pharmaceutical Preparations 4%
• Therapeutics 1%